Canadian Medical Hall of Fame

Tomorrow’s medical history is being made today. 

He blazed a remarkable trail in the molecular biology of the immune system and in cancer.


The Canadian Medical
Hall of Fame

The world’s only national Hall of Fame dedicated to celebrating the accomplishments of medical heroes.

The Canadian Medical Hall of Fame contributes to a vibrant health care system by engaging Canada’s health leaders in educational programs that encourage youth to pursue careers in health sciences.

Learn more about us         Support us

Dr. Cynader obtained his BSc at McGill University in 1967 and his PhD from the Massachusetts Institute of Technology in 1972. Following postdoctoral training, Dr. Cynader held positions at Dalhousie University in Halifax and joined the University of British Columbia (UBC) as Professor and Director of the Ophthalmology Research Group in 1988. He was appointed Founding Director of the Brain Research Centre in 1998 and more recently, the Djavad Mowafaghian Centre for Brain Health at Vancouver Coastal Health and UBC, which he helped build.Dr. Cynader has authored more than 200 articles published in scientific journals, has presented more than 350 papers at national and international scientific meetings, and is the holder of several patents. He has made important contributions to technology development and to the commercialization of research results including the development of gene therapy products to treat brain diseases. Dr. Cynader’s work in understanding how sound is processed by the brain was used to develop a new “listening chip” which has found many applications from intelligent hearing aids to advanced dictation systems. In founding and successfully nurturing various companies, Dr. Cynader has contributed to the development of Canada’s high tech and biotech communities.Dr. Cynader is a passionate spokesperson for brain health, often using his unique ability to explain complex concepts in lay terms to capture the interest of local, national and international audiences.Recognition for his many achievements includes the Order of Canada, Order of British Columbia, Researcher of the Year from Life Sciences BC, Science and Technology Champion award by Innovation BC, Canada Research Chair, Gold Medal in Health Sciences, Killam Research Prize and E.W.R. Steacie Fellowship), among others. He is a Fellow of The Royal Society of Canada and The Canadian Academy for Health Sciences and a Principal Investigator in Canada’s Network of Excellence in Stroke.
2014 Inductee
Dr. de Bold undertook his university training in the Faculty of Chemical Sciences at the National University of Córdoba, Argentina, where he obtained a professional degree in Clinical Biochemistry. He then completed his residency training in Laboratory Medicine at the Hospital Nacional de Clínicas, where he was Chief Resident.In 1968, after meeting a Queen’s faculty member in Argentina, Dr. de Bold made the adventurous move to Canada to continue his research and studies in the Department of Pathology at Queen’s University in Kingston, Ontario. There he obtained a PhD in Experimental Pathology and was appointed to academic staff in 1974. It was in Kingston that Dr. de Bold raised the profile of our entire country with respect to health research and innovation with his ground breaking discovery in 1981.A Professor at Queen’s University until 1986, he then moved to the nation’s capital and was influential in establishing the Research Centre at the University of Ottawa Heart Institute where he was the Director of the Cardiovascular Endocrinology Laboratory and is now an Emeritus Professor in the Faculty of Medicine.One of Canada’s most cited authors, Dr. de Bold’s work has provided the basis for ever expanding scientific literature which now totals more than 18,000 published manuscripts. He has given more than 180 invited lectures worldwide during his illustrious career. In recognition of his outstanding contributions to cardiovascular research, Dr. de Bold has received numerous national and international honours including the Queen’s University Prize for Excellence in Research, the Gairdner Foundation International Award, The Royal Society of Canada McLaughlin Medal in Medical Research, the American Heart Association CIBA prize, the International Hypertension Society Prize, the “Living Legend” Award from the International Society of Cardiothoracic Surgeons, the CIHR-Canadian Medical Association Journal’s Top Canadian Achievements in Health Research Award and his work on ANF was declared the first of the top 10 research accomplishments funded by the Heart and Stroke Foundation of Ontario in the past 50 years. Dr. de Bold is an Officer of the Order of Canada and an elected Fellow of the Royal Society of Canada, the Royal College of Physicians and Surgeons of Canada, the American Heart Association, the International Academy of Cardiovascular Sciences and the American Society for the Advancement of Science.  He is the 2014 recipient of Le Grand Prix scientifique de la Fondation Lefoulon Delalande Institut de France.
2014 Inductee
Dr. Mackenzie received his BSc in 1927 and MD in 1932 from Dalhousie University and was honored as one of two Malcolm Honor Society Medal Winners. He began surgery training at McGill then moved to the Mayo Clinic in 1933 to complete his MSc.In 1938, his new surgical practice in Edmonton was soon interrupted by service in the Royal Canadian Navy where he was rapidly promoted to Surgeon-Commander. He retired in 1945 having been awarded a Star Medal, the CVSM Medal, War Medal and a Defense Medal for his service to Canada.From instructor at the University of Alberta, Dr. Mackenzie rose to Professor and Chair of the Department of Surgery in 1950. In short order he established seven sub-specialty departments and implemented rigorous standards for the selection of staff, assessing soft skills alongside research achievements, not a typical approach in the early sixties. As Dean of the Faculty of Medicine from 1959 to 1974 he transformed the medical school with a commitment to excellence, growing research funding from $500,000 to well over $4 million, attracting world class talent to work in an equally world class environment while helping to build the McEachern Laboratory and the Surgical-Medical Research Laboratory. His proactive work with Premier Peter Lougheed inspired the concept of the Alberta Heritage Foundation for Medical Research.Dr. Mackenzie was president of 12 of the 25 medical organizations to which he belonged including the American College of Surgeons and Royal College of Physicians and Surgeons of Canada. Conducting a very busy surgical practice in conjunction with his various medical administrative responsibilities, he published 80 peer-reviewed papers and was recognized with four international fellowships, three honorary degrees and many prestigious awards including the Order of Canada during its inaugural year and the very prestigious FNG Starr Award by the Canadian Medical Association.
2014 Inductee
Dr. Murray completed his undergraduate education at St. Francis Xavier University and graduated with honours from Dalhousie Medical School in 1963. Following two years in general practice, he trained in internal medicine and then in neurology in Halifax, London, and Toronto before joining the Dalhousie medical faculty in 1970. He became Professor of Medicine, Head of Neurology, Dean of Medicine, and Professor of Medical Humanities.As Dean of Medicine from 1985 to 1992, he proved himself an innovator in medical education creating a trendsetting, problem-based, tutorial format curriculum in the undergraduate years and a world-respected program in the medical humanities, fostering other related disciplines – artists and writers in residence, theatre, music and literature. He once wrote: “We need science, but science also needs the humanities to understand human values and the human questions and the human decisions that must guide our use of science.”Dr. Murray has more than 300 medical publications, nine books, 43 text book chapters, and has held 91 funded research grants. He was a member of the Working Group on Disability in US Presidents which presented its report to President Clinton at the White House in 1996. He was Chairman of both the Board of Governors and Board of Regents of the American College of Physicians, President of the American Osler Society and President of the Canadian Society for the History of Medicine. His many honors include a mastership in the American College of Physicians, the Dr. A. B. Baker Award for Lifetime Achievement in Neurological Education from the Academy of Neurology, the Scheinberg Award for Lifetime Contributions to Multiple Sclerosis from the Consortium of Multiple Sclerosis Centres, Mentor of the Year Award from the Royal College of Physicians and Surgeons of Canada, and five honorary degrees. He is an Officer of the Order of Canada appointed to the Order of Nova Scotia.
2014 Inductee
Dr. Worton earned his Bachelor and Master of Science degrees, both in physics, from the University of Manitoba in 1964 and 1965. He then moved to the University of Toronto where he obtained his PhD in Medical Biophysics in 1969 under the guidance of Drs. James Till and Ernest McCulloch.He developed his interest in genetics during his postdoctoral fellowship at Yale University and then joined the Department of Genetics at The Hospital for Sick Children (SickKids) in Toronto as Director of the Cytogenetics Laboratory in 1971.In 1985 he began a ten year term as Geneticist-in-Chief at the hospital, during which time his genetics department led the world with the discovery of genes responsible for muscular dystrophy (Worton and Ray), cystic fibrosis (Tsui), Wilson’s disease (Cox), Tay-Sachs disease (Gravel) and Fanconi anemia (Buchwald).In 1996 Dr. Worton moved to Ottawa where he led the development of the Ottawa Hospital Research Institute by bringing together a number of smaller institutes under one administrative structure, coupled with extensive recruitment of basic scientists and clinical investigators. Under his tenure the Institute grew to be one of the top health research institutes in Canada and remains so today.Dr. Worton’s national and international leadership roles include four years on the Board of the Human Genome Organization (HUGO), 12 years as Associate Director of the Canadian Genetic Diseases Network, six years as Head of the Canadian Genome Analysis and Technology Program and four years as Founding Scientific Director of Canada’s Stem Cell Network. His honors and awards include a Gairdner Foundation International Award, election as a Fellow of the Royal Society of Canada, an honorary Fellow of the Royal College of Physicians and Surgeons of Canada and an Officer of the Order of Canada.
2014 Inductee
Medically qualified in Bangalore in 1976, Dr. Yusuf received a Rhodes Scholarship and earned a DPhil from Oxford, during which time he (along with Richard Peto and Peter Sleight) initiated the concepts of large, simple trials, and meta-analysis. He coordinated the ISIS trial which set the structure for future international collaborative work in cardiovascular disease and demonstrated the value of beta-blockers in myocardial infarction.In 1984, Dr. Yusuf moved to the National Institutes of Health in Bethesda, USA, where he was a leader in their SOLVD trial (establishing the value of ACE inhibitors in LV dysfunction) and DIG trial (clarifying the role of digitalis). In 1992 he moved to McMaster University, where he established an international program of research in cardiovascular diseases and prevention, culminating in the creation of the Population Health Research Institute, which he founded and heads. The work by his group has lead to a better understanding of risk factors for heart disease and strokes globally, the discovery of new treatments such as ACE inhibitors, dual antiplatelets, and novel antithrombotic agents to reduce mortality, heart attacks and strokes. His current work explores the role of the environment, health policies and health systems in influencing cardiovascular disease mortality globally.Dr. Yusuf’s influence on international researchers is perhaps one of his most enduring gifts. By involving researchers in collaborative networks, and by providing practical training in the conduct of productive research projects, he has helped establish a much deeper understanding of the key principles that underlie epidemiological research in an astounding number of research fellows who have benefited from his direct supervision.Dr. Yusuf holds a Heart and Stroke Foundation of Ontario Research Chair, was a Senior Scientist of the Canadian Institutes of Health Research (1999 – 2004), and has received more than 40 international and national awards for research including in 2014 the Gairdner Wightman Prize, induction into the Royal Society of Canada and appointment as an Officer of the Order of Canada.He has published more than 800 articles in refereed journals, rising to the second most cited researcher in the world for 2011. He is President-elect of the World Heart Federation, where he is initiating an Emerging Leaders program in 100 countries with the aim of halving the CVD burden globally within a generation.
2014 Inductee